Nava Greenfield, MD
Dermatology · Concord, NHNPI 1093080202
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,330 of the $8,392 with a category attached, or 87.3%. It is spread thinly across 27 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations.
Across 463 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pfizer$1K
- BD$990
- Novartis$472
- LEO Pharma Inc.$411
- Dermavant Sciences, Inc.$406
- plus $3K from 21 others
What the payments were for
- Consulting fees$99012%
- Food & beverage$7,33087%
- Education$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 106 | $1,697 |
| Pfizer | 70 | $1,209 |
| BD | 1 | $990 |
| Novartis | 24 | $472 |
| LEO Pharma Inc. | 36 | $411 |
| Dermavant Sciences, Inc. | 32 | $406 |
| Incyte Corporation | 37 | $363 |
| Regeneron Healthcare Solutions, Inc. | 16 | $324 |
| Johnson & Johnson | 20 | $306 |
| Amgen | 11 | $269 |
| Galderma Laboratories, L.p. | 15 | $251 |
| Arcutis Biotherapeutics, Inc. | 9 | $194 |
| Mayne Pharma Commercial LLC | 23 | $193 |
| Sanofi | 8 | $184 |
| Almirall LLC | 8 | $169 |
| Biofrontera Inc. | 3 | $154 |
| Sun Pharmaceutical Industries Inc. | 9 | $142 |
| E.r. Squibb & Sons, L.L.C. | 8 | $138 |
| Lilly USA, LLC | 6 | $118 |
| Journey Medical Corporation | 6 | $115 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $107 |
| Dermira, Inc. | 3 | $62 |
| Cipher Pharmaceuticals US LLC | 1 | $33 |
| Botanix SB Inc | 1 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| EPI Health, LLC | 1 | $19 |
| Bristol Myers Squibb | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$289
- AMELUZ$122
- BF-RhodoLED$122
- XEPI$122
How this compares
$8,392 in reported general payments places this provider in the 80th percentile of 75 dermatology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelaic Acid | 12 | $1,463 |
| Clobetasol Propionate | 17 | $1,158 |
| Fluorouracil | 12 | $1,115 |
| Clindamycin Phosphate | 22 | $897 |
| Ketoconazole | 57 | $871 |
| Triamcinolone Acetonide | 46 | $376 |
| Doxycycline Hyclate | 18 | $245 |
| Hydrocortisone | 54 | $236 |
| Mupirocin | 31 | $209 |
| Minoxidil | 12 | $159 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Concord
- Andrew KimConcord$11K
- Ebaa AlawamiConcord$11K
- Anthony AversaConcord$9K
- Alexandra CharosConcord$2K
- Scott DeckelbaumConcord$1K
- Paul EspyConcord$153
- Peter SandsConcord$80
- Abel JarellPortsmouth$2.3M
- Robert PosnickNashua$951K
- David PosnickNashua$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.